Female Health Stock Fundamentals
| FMW Stock | EUR 0.64 0.05 8.47% |
FEMALE HEALTH fundamentals help investors to digest information that contributes to FEMALE HEALTH's financial success or failures. It also enables traders to predict the movement of FEMALE Stock. The fundamental analysis module provides a way to measure FEMALE HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FEMALE HEALTH stock.
FEMALE |
FEMALE HEALTH Company Price To Sales Analysis
FEMALE HEALTH's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current FEMALE HEALTH Price To Sales | 11.03 X |
Most of FEMALE HEALTH's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FEMALE HEALTH is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, FEMALE HEALTH has a Price To Sales of 11.0273 times. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The price to sales for all Germany stocks is notably lower than that of the firm.
FEMALE HEALTH Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining FEMALE HEALTH's current stock value. Our valuation model uses many indicators to compare FEMALE HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FEMALE HEALTH competition to find correlations between indicators driving FEMALE HEALTH's intrinsic value. More Info.FEMALE HEALTH is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in price to book category among its peers . The ratio of Current Valuation to Price To Book for FEMALE HEALTH is about 64,859,995 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FEMALE HEALTH's earnings, one of the primary drivers of an investment's value.FEMALE Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FEMALE HEALTH's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FEMALE HEALTH could also be used in its relative valuation, which is a method of valuing FEMALE HEALTH by comparing valuation metrics of similar companies.FEMALE HEALTH is currently under evaluation in price to sales category among its peers.
FEMALE Fundamentals
| Current Valuation | 350.37 M | |||
| Price To Book | 5.40 X | |||
| Price To Sales | 11.03 X | |||
| Revenue | 39.35 M | |||
| EBITDA | (78.96 M) | |||
| Net Income | (83.78 M) | |||
| Total Debt | 9.66 M | |||
| Cash Flow From Operations | (47.51 M) | |||
| Market Capitalization | 442.9 M | |||
| Total Asset | 136.13 M | |||
| Z Score | 27.0 | |||
| Net Asset | 136.13 M |
About FEMALE HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FEMALE HEALTH's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FEMALE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FEMALE HEALTH based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in FEMALE Stock
FEMALE HEALTH financial ratios help investors to determine whether FEMALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FEMALE with respect to the benefits of owning FEMALE HEALTH security.